Author
Hospital Universitario 12 De OctubreORCID 0000-0002-6578-7153Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
3 papers
Recent·Most cited
Iris Lodewijk, Carolina Rubio, Pontus Eriksson…·Marta Dueñas
This study identifies CD44v6 as a driver of bladder cancer aggressiveness and chemoresistance, linking its expression to poor patient outcomes and therapeutic resistance.
Ana García García, María Ferrer Aporta, Germán Vallejo-Palma…·Victor Javier Sanchez-Arevalo Lobo
This study identifies ELOVL6 as a therapeutic target in pancreatic cancer by showing its role in c-MYC-driven lipid metabolism and its impact on chemotherapy efficacy.
Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui…·Luis Álvarez‐Vallina
This study shows that engineered CD4+ TIL secreting TCE can induce tumor regression in NSCLC PDX models by redirecting non-tumor dominant T cell clones.